This systematic review had a clear objective; to address whether previous randomized controlled studies on peri-implantitis therapy use appropriate true endpoints or surrogate endpoints only. The authors made an extensive search of the literature by using Pubmed, Cochrane and Lilacs. However, they did not mention whether the language was limited or not. Medline and Embase were not used. Grey literature was searched in English, German, French, Spanish and Italian by Google. One possible drawback to this study is that the authors did not present the definition of peri-implantitis in collecting the articles. As peri-implantitis is not a fully defined disease entity yet, it seems to be a necessary measure to define the peri-implantitis in the inclusion/exclusion criteria.
Surrogate endpoints are clinical or lab values that are expected to serve as a reliable substitute for true endpoints. True endpoints in the periodontitis or peri-implantitis treatment would be tooth or implant maintenance or failure. Traditionally used surrogate endpoints on the periodontal therapy were; pocket probing depth, clinical attachment level, bleeding on probing. Sufficient evidence exists to support the view that surrogate endpoints might not reflect true endpoint in the case of chronic disease, 1 which applies also in case of peri-implantitis. Thus, the review's authors have appropriately addressed narrowly focused questions.
The authors made an extensive search of the literature by using Pubmed, Cochrane and Lilacs. However, they did not mention whether the language was limited or not. Medline and Embase were not used. Grey literature was searched in English, German, French, Spanish and Italian by Google. One possible drawback to this study is that the authors did not present the definition of peri-implantitis in collecting the articles. As peri-implantitis is not a fully defined disease entity yet, it seems to be a necessary measure to define the peri-implantitis in the inclusion/exclusion criteria.
The result of this review indicates that those surrogate endpoints were repeatedly used on the peri-implantitis studies, while true endpoints (implant failures) were reported as a consequence of peri-implantitis therapy, not as an objective of an investigation.
The results were not presented as meta-analysis, but the types and the frequency of endpoints were presented. However, meta-analysis in this review would be unnecessary, since it was clearly mentioned that the objective of this review was to report the types and frequency of endpoints usage.
As the authors pointed out, there is clearly a need for more validated surrogate endpoints in lieu of true clinical endpoint in peri-implantitis therapy. However, there is also a concern that, in using 'implant failure' as the only endpoint in the peri-implantitis therapy, this could fail to discriminate between effective therapy for acquiring appropriate mucosal seal around implant and noneffective therapy. Scholar, hand searching of websites of major dental journals. The reference list of five recently published systematic reviews on peri-implantitis treatment were also screened for potential studies. Question: Do studies on treatment for peri-implantitis use true endpoints for outcome?
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• Traditionally used clinical surrogate endpoints for peri-implantitis treatments are possibly not indicating the true endpoint (implant removal), thus further validation is necessary.
